000 01071 a2200301 4500
005 20250516193346.0
264 0 _c20150217
008 201502s 0 0 ger d
022 _a1615-6692
024 7 _a10.1007/s00059-013-4013-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCustodis, F
245 0 0 _a[Treatment of lipid disorders].
_h[electronic resource]
260 _bHerz
_cFeb 2014
300 _a119-28; quiz 129-30 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article
650 0 4 _aCombined Modality Therapy
_xmethods
650 0 4 _aExercise Therapy
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xadministration & dosage
650 0 4 _aHyperlipidemias
_xdiagnosis
650 0 4 _aHypolipidemic Agents
_xadministration & dosage
650 0 4 _aRisk Reduction Behavior
650 0 4 _aSmoking Cessation
700 1 _aLaufs, U
773 0 _tHerz
_gvol. 39
_gno. 1
_gp. 119-28; quiz 129-30
856 4 0 _uhttps://doi.org/10.1007/s00059-013-4013-x
_zAvailable from publisher's website
999 _c23490301
_d23490301